Sinobay
About:
Sinobay develops biotechnology for tumor treatment and the proliferation of CD8+T & CAR-T cells in vitro.
Website: http://www.sinobay.sh.cn
Top Investors: Lead Capital
Description:
Total Funding Amount:
10M CNY
Headquarters Location:
Jinshan, Shanghai, China
Founded Date:
2017-12-29
Founders:
Number of Employees:
51-100
Last Funding Date:
2018-02-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai